IBDEI0GN ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8049,2)
 ;;=^269053
 ;;^UTILITY(U,$J,358.3,8050,0)
 ;;=373.31^^52^577^49
 ;;^UTILITY(U,$J,358.3,8050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8050,1,3,0)
 ;;=3^Eyelid,Dermatitis,Eczematous
 ;;^UTILITY(U,$J,358.3,8050,1,4,0)
 ;;=4^373.31
 ;;^UTILITY(U,$J,358.3,8050,2)
 ;;=^269060
 ;;^UTILITY(U,$J,358.3,8051,0)
 ;;=373.34^^52^577^52
 ;;^UTILITY(U,$J,358.3,8051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8051,1,3,0)
 ;;=3^Eyelid,Lupus Erythematosus,Discoid
 ;;^UTILITY(U,$J,358.3,8051,1,4,0)
 ;;=4^373.34
 ;;^UTILITY(U,$J,358.3,8051,2)
 ;;=^269064
 ;;^UTILITY(U,$J,358.3,8052,0)
 ;;=373.9^^52^577^37
 ;;^UTILITY(U,$J,358.3,8052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8052,1,3,0)
 ;;=3^Eyelid Inflammation,NOS
 ;;^UTILITY(U,$J,358.3,8052,1,4,0)
 ;;=4^373.9
 ;;^UTILITY(U,$J,358.3,8052,2)
 ;;=^269070
 ;;^UTILITY(U,$J,358.3,8053,0)
 ;;=374.21^^52^577^75
 ;;^UTILITY(U,$J,358.3,8053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8053,1,3,0)
 ;;=3^Lagophthalmos,Paralytic
 ;;^UTILITY(U,$J,358.3,8053,1,4,0)
 ;;=4^374.21
 ;;^UTILITY(U,$J,358.3,8053,2)
 ;;=^269091
 ;;^UTILITY(U,$J,358.3,8054,0)
 ;;=374.22^^52^577^74
 ;;^UTILITY(U,$J,358.3,8054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8054,1,3,0)
 ;;=3^Lagophthalmos,Mechanical
 ;;^UTILITY(U,$J,358.3,8054,1,4,0)
 ;;=4^374.22
 ;;^UTILITY(U,$J,358.3,8054,2)
 ;;=^269093
 ;;^UTILITY(U,$J,358.3,8055,0)
 ;;=374.23^^52^577^73
 ;;^UTILITY(U,$J,358.3,8055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8055,1,3,0)
 ;;=3^Lagophthalmos,Cicatricial
 ;;^UTILITY(U,$J,358.3,8055,1,4,0)
 ;;=4^374.23
 ;;^UTILITY(U,$J,358.3,8055,2)
 ;;=^269095
 ;;^UTILITY(U,$J,358.3,8056,0)
 ;;=374.31^^52^577^42
 ;;^UTILITY(U,$J,358.3,8056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8056,1,3,0)
 ;;=3^Eyelid Ptosis,Paralytic
 ;;^UTILITY(U,$J,358.3,8056,1,4,0)
 ;;=4^374.31
 ;;^UTILITY(U,$J,358.3,8056,2)
 ;;=^269097
 ;;^UTILITY(U,$J,358.3,8057,0)
 ;;=374.32^^52^577^41
 ;;^UTILITY(U,$J,358.3,8057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8057,1,3,0)
 ;;=3^Eyelid Ptosis,Myogenic
 ;;^UTILITY(U,$J,358.3,8057,1,4,0)
 ;;=4^374.32
 ;;^UTILITY(U,$J,358.3,8057,2)
 ;;=^269098
 ;;^UTILITY(U,$J,358.3,8058,0)
 ;;=374.33^^52^577^40
 ;;^UTILITY(U,$J,358.3,8058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8058,1,3,0)
 ;;=3^Eyelid Ptosis,Mechanical
 ;;^UTILITY(U,$J,358.3,8058,1,4,0)
 ;;=4^374.33
 ;;^UTILITY(U,$J,358.3,8058,2)
 ;;=^269099
 ;;^UTILITY(U,$J,358.3,8059,0)
 ;;=374.34^^52^577^26
 ;;^UTILITY(U,$J,358.3,8059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8059,1,3,0)
 ;;=3^Eyelid Blepharochalasis/Pseudoptosis
 ;;^UTILITY(U,$J,358.3,8059,1,4,0)
 ;;=4^374.34
 ;;^UTILITY(U,$J,358.3,8059,2)
 ;;=^15275
 ;;^UTILITY(U,$J,358.3,8060,0)
 ;;=374.41^^52^577^44
 ;;^UTILITY(U,$J,358.3,8060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8060,1,3,0)
 ;;=3^Eyelid Retraction/Lag
 ;;^UTILITY(U,$J,358.3,8060,1,4,0)
 ;;=4^374.41
 ;;^UTILITY(U,$J,358.3,8060,2)
 ;;=^269101
 ;;^UTILITY(U,$J,358.3,8061,0)
 ;;=374.43^^52^577^25
 ;;^UTILITY(U,$J,358.3,8061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8061,1,3,0)
 ;;=3^Eyelid Abn Innervation Synd
 ;;^UTILITY(U,$J,358.3,8061,1,4,0)
 ;;=4^374.43
 ;;^UTILITY(U,$J,358.3,8061,2)
 ;;=^269102
 ;;^UTILITY(U,$J,358.3,8062,0)
 ;;=374.46^^52^577^27
 ;;^UTILITY(U,$J,358.3,8062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8062,1,3,0)
 ;;=3^Eyelid Blepharophimosis
 ;;^UTILITY(U,$J,358.3,8062,1,4,0)
 ;;=4^374.46
 ;;^UTILITY(U,$J,358.3,8062,2)
 ;;=^15279
 ;;^UTILITY(U,$J,358.3,8063,0)
 ;;=374.50^^52^577^30
 ;;^UTILITY(U,$J,358.3,8063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8063,1,3,0)
 ;;=3^Eyelid Degen D/O,Unspec
